CRAD-B C-Rad AB (publ)

STO · SE · Healthcare · Medical Devices · c-rad.com

34.20SEK0.00%Mkt Cap: 107.89M $P/E: 23.113d ago

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company off…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap107.89M USD

Enterprise Value-9.53M USD

Revenue (TTM)42.51M USD

Gross Profit30.23M USD

Net Income (TTM)1.00M USD

Revenue/Share13.27 SEK

Last Price34.20 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees98

CountrySE

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)23.11

P/E (Forward)15.13

PEG—

EV/EBITDA-1.17

EV/Revenue-0.22

P/S2.54

P/B0.08

EPS (TTM)1.48

EPS (Forward)2.26

52W Range

24.6065% of range39.40

52W High39.40 SEK

52W Low24.60 SEK

Profitability

Gross Margin71.52%

Oper. Margin18.49%

EBITDA Margin19.09%

Profit Margin2.37%

ROE3.01%

ROA2.09%

Growth

Revenue Growth15.70%

Earnings Growth505.00%

Cash Flow & Leverage

Operating CF6.80M USD

CapEx (TTM)1.99M USD

FCF Margin2.11%

FCF Yield0.83%

Net Debt-12.35M USD

Net Debt/EBITDA-1.52

Balance Sheet

Debt/Equity0.03

Current Ratio3.34

Quick Ratio2.63

Book Value/Sh424.62 SEK

Cash/Share160.16 SEK

Dividends

Fwd Div Rate0.10 SEK

Trail. Div Rate0.10 SEK

Div. Yield0.29%

5Y Avg Yield—

Payout Ratio6.76%

Ex-Div DateMay 8, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)45.00 SEK

Upside (mean)+31.6%

Target Range45.00 SEK – 45.00 SEK

# Analysts1

Ownership

Shares Out.32.12M

Float560.87K

Insiders46.23%

Institutions28.33%

Technical

SMA 5035.18 (-2.8%)

SMA 20032.25 (+6.1%)

Beta0.74

S&P 52W Chg14.58%

Avg Vol (30d)20.45K

Avg Vol (10d)30.84K

Technical Indicators

RSI (14)48.4

MACD-0.5240

MACD Signal-0.5069

MACD Hist.-0.0170

BB Upper36.02 SEK

BB Middle34.31 SEK

BB Lower32.60 SEK

BB Width9.99%

ATR (14)1.010 SEK

Vol Ratio (20d)0.30x